Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD44 identified as a diagnostic biomarker for highly malignant CA19-9 negative pancreatic cancer

9 Apr 2025

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer Genomics and Diagnostics
Share to Pancreatic and Hepatic Oncology Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 40216152
DOI: 10.1016/j.canlet.2025.217713

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD44 identified as a diagnostic biomarker for highly malignant CA19-9 negative pancreatic cancerPMID 40216152Read ↗

Progress on molecular markers of pancreatic cancerSemantic proximity Read ↗

Current State of “Omics” Biomarkers in Pancreatic CancerSemantic proximity Read ↗

CD44 as a potential diagnostic tumor markerSemantic proximity Read ↗

Current status of CD44 variant isoforms as cancer diagnostic markers.Semantic proximity Read ↗

Emerging Prognostic and Predictive Factors in Pancreatic CancerSemantic proximity Read ↗

Optimal value of CA19-9 determined by KRAS-mutated circulating tumor DNA contributes to the prediction of prognosis in pancreatic cancer patients.Semantic proximity Read ↗

Identification of potential diagnostic biomarkers in MMPs for pancreatic carcinomaSemantic proximity Read ↗

Significance of CD44 gene products for cancer diagnosis and disease evaluationSemantic proximity Read ↗

Molecular prognostic markers in pancreatic cancerSemantic proximity Read ↗

Novel blood-based microRNA biomarker panel for early diagnosis of pancreatic cancerSemantic proximity Read ↗

CD99 is a potential diagnostic and immunological biomarker in pan-cancerSemantic proximity Read ↗

Plasma miRNAs Effectively Distinguish Patients With Pancreatic Cancer From ControlsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.